Cystic Fibrosis (CF)
Conditions
Keywords
Cystic Fibrosis, Magnetic Resonance Imaging, Ultrashort Echo Time, Multiple Breath Washout, Airways
Brief summary
This study is being done to determine whether MRI can produce high quality lung and airway images in healthy and CF patients and if MRI can be used to evaluate size and shape of the airways with computer assistance. This study will also repeat MRI experiments two years after the initial MRI scan to see if changes to airway size and shape are seen over time. In a subset of participants, we will investigate whether MRI results are repeatable and reproducible in the short-term one week after the initial MRI visit. This study will help understand if MRI based measurements of airway size and shape can be used as a monitoring tool that does not use x-ray radiation in patients with CF.
Detailed description
Early CF disease in the lungs is characterized by repeated infection which can alter dimensions of the airways , especially abnormal dilation of the airways (bronchiectasis) Airway tree mapping is a form of quantitative imaging that investigates segmentation and dimensionality of the upper airways. CT detects utilized to characterize airway dimension in adults with COPD, but involves ionizing radiation. Unexplored in children. MRI: Non-invasive, radiation-free, ideal for longitudinal monitoring. However, struggles with lung imaging due to low signal intensity, short T2 relaxation times, and motion artifacts Advanced ultrashort echo time (UTE) MRI enables high-resolution airway imaging with motion correction for free-breathing airway imaging. May permit airway tree mapping in children while obviating ionizing radiation risk.
Interventions
UTE lung MRI with various parameters will be done to determine optimal image quality for airway segmentation. The average scanning time for each sequence is in the order of 10 minutes.
Lung clearance index (LCI) will be determined by nitrogen multiple breath washout using the Exhalyzer D for measurement of inert gas washout. LCI measures will be taken in triplicate to ensure reproducibility.
Sponsors
Study design
Eligibility
Inclusion criteria
Group 1 Inclusion Criteria: * Participants must be greater than or equal to 6 years of age and not greater than 18 years of age. * Informed consent by patient or parent/guardian consent and participant assent when appropriate. * Able to perform reproducible spirometry
Exclusion criteria
* Medical instability that would preclude the ability to undergo the required investigations * FEV1 % predicted \< 40% * Severe claustrophobia * Does not meet MRI screening criteria * Usage of oral antibiotics within 3 weeks prior to study visit * Known pulmonary disease Group 2 Inclusion Criteria * Diagnosis of CF as evidenced by one or more clinical feature consistent with the CF phenotype or positive CF newborn screen * Participants must be greater than or equal to 6 years of age and not greater than 18 years of age. * Informed consent by patient or parent/guardian consent and participant assent when appropriate. * Able to perform reproducible spirometry
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Airway Lumen Diameter measured by UTE MRI | Baseline (Visit 1A); Optional 1-week repeatability visit (Visit 1B) & 2-year follow-up (Visit 2A) | Quantitative measurement of airway lumen diameter (millimeters) across airway generations 1-6 using UTE MRI airway tree segmentation. |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Lung Clearance Index (LCI) | Baseline (Visit 1A); Optional 1-week repeatability visit (Visit 1B) & 2-year follow-up (Visit 2A) | LCI measured with nitrogen Multiple Breath Washout (MBW). |
Countries
Canada
Contacts
The Hospital for Sick Children